arrow_back Back to App

Designating September 25th as National Ataxia Awareness Day

The U.S. Senate designates September 25, 2024, as National Ataxia Awareness Day. This resolution aims to boost public and professional knowledge about Ataxia, a group of rare neurodegenerative diseases affecting coordination. The goal is to accelerate research for effective treatments and improve diagnosis and access to care for affected individuals and their families.
Key points
Official designation of September 25th to raise public awareness of Ataxia, a rare neurodegenerative disease.
Support for efforts to improve diagnosis, access to care, and accelerate research into treatments and a cure for Ataxia.
Recognition of the significant physical and financial challenges faced by patients and their families due to this condition.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_794
Sponsor: Sen. Hyde-Smith, Cindy [R-MS]
Process start date: 2024-08-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating September 25, 2024, as "National Ataxia Awareness Day", and raising awareness of ataxia, ataxia research, and the search for a cure.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_794.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-08-01.

What are the main provisions?

Key points include:

  • Official designation of September 25th to raise public awareness of Ataxia, a rare neurodegenerative disease.
  • Support for efforts to improve diagnosis, access to care, and accelerate research into treatments and a cure for Ataxia.
  • Recognition of the significant physical and financial challenges faced by patients and their families due to this condition.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hyde-Smith, Cindy [R-MS].

What is the latest detailed status?

The latest detailed status is: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S5946; text: 08/01/2024 CR S5786-5787)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health